Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

IVVD Invivyd Inc

1,21

-0,03 (-2,42%)

Avant marché

Dernière mise à jour : 12:20:33

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

05/16/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ David Neil Hering

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Invivyd (NASDAQ:IVVD)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025

Plus de graphiques de la Bourse Invivyd

Invivyd (NASDAQ:IVVD)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025

Plus de graphiques de la Bourse Invivyd

Actualités Invivyd Inc

Form 8-K - Current report
Lundi 24 Février 2025 ( il y a 23 heures) • Edgar (US Regulatory)

FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the Existi
Lundi 24 Février 2025 ( il y a 24 heures) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 19 Février 2025 ( il y a 6 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 19 Février 2025 ( il y a 6 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 19 Février 2025 ( il y a 6 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 19 Février 2025 ( il y a 6 jours) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mercredi 12 Février 2025 ( il y a 2 semaines) • Edgar (US Regulatory)

Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025
Lundi 10 Février 2025 ( il y a 2 semaines) • GlobeNewswire Inc.

Invivyd Announces Partnership with Pro Football Coach Jim Harbaugh to Elevate Awareness and Ongoing Impact of COVID-19: Common, Not A Cold
Mercredi 5 Février 2025 ( il y a 3 semaines) • GlobeNewswire Inc.

Form 8-K - Current report
Lundi 3 Février 2025 ( il y a 3 semaines) • Edgar (US Regulatory)

Invivyd Announces Positive Phase 1/2 Clinical Data for VYD2311, a Monoclonal Antibody Designed to be a Superior Alternative to COVID-19 Vaccination for the Broad Population
Lundi 3 Février 2025 ( il y a 3 semaines) • GlobeNewswire Inc.

Invivyd Announces Preliminary Fourth Quarter 2024 Financial Results, Strong Revenue Growth, and Reiterates Goal of Near-Term Profitability
Lundi 3 Février 2025 ( il y a 3 semaines) • GlobeNewswire Inc.

Plus d'articles sur Invivyd Inc

Credit Agricole

Cie de SaintGobain

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales